Myocardial protective effects of nicorandil, an opener of potassium channels on senile rat heart

Perfusion

Volumn 21, Issue 3, 2006, Pages 179-183

  Liu, Jinping ^a,c   Long, Cun ^a   Ji, Bingyang ^a,b   Zhang, Hongjia ^a   Wen, Fuxing ^a  

^a FUWAI HOSPITAL   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c NONE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; CREATINE KINASE MB; LACTATE DEHYDROGENASE; NICORANDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; ST THOMAS HOSPITAL SOLUTION;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DRUG EFFECT; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE FIBRILLATION; HYPOTHERMIA; INCIDENCE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; ULTRASTRUCTURE;

AGING; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIAC OUTPUT; CREATINE KINASE; DRUG EVALUATION, PRECLINICAL; FEVER; HEART VENTRICLES; HYDRO-LYASES; MYOCARDIAL REPERFUSION INJURY; NICORANDIL; ORGAN CULTURE TECHNIQUES; PERFUSION; POTASSIUM CHANNELS; RATS; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 33745389071     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216306pf858oa     Document Type: Article

References (21)

1. Willems L, Garnham B, Headrick JP. Aging-related changes in myocardial purine metabolism and ischemic tolerance. Exp Gerontol 2003; 38: 1169-77.
2. Bartling B, Friedrich I, Silber RE. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann Thorac Surg 2003; 76: 105-11.
3. Gomma AH, Purcell HJ, Fox KM. Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil. Drugs 2001; 61: 1705-10.
4. Gross GJ, Auchampach JA. Role of ATP-dependent potassium channels in myocardial ischaemia. Cardiovasc Res 1992; 26:1011-16.
5. Gross GJ. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol 1995; 90: 85-88.
6. Jayawant M, Stephenson ER Jr, Damiano RJ Jr et al. Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas' Hospital solution during prolonged ischemia. J Thorac Cardiovasc Surg 1998; 116: 131-38.
7. Damiano RJ Jr, Cohen NM. Hyperpolarized arrest attenuates myocardial stunning following global surgical ischemia: an alternative to traditional hyperkalemic cardioplegia? J Card Surg 1994; 9: 517-25.
8. Fremes SE, Weisel RD, Mickle DA et al. Myocardial metabolism and ventricular function following cold potassium cardioplegia. J Thorac Cardiovasc Surg 1985; 89: 531-46.
9. Garnier-Raveaud S, Faury G, Mazenot C et al. Highly protective effects of chronic oral administration of nicorandil on the heart of ageing rats. Clin Exp Pharmacol Physiol 2002; 29: 441-48.
10. Li Y, Iguchi A, Tsuru Y et al. Nicorandil pretreatment and improved myocardial protection during cold blood cardioplegia. Jpn J Thorac Cardiovasc Surg 2000; 48: 24-29.
11. Hayashi Y, Sawa Y, Ohtake S. Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting. J Cardiovasc Pharmacol 2001; 38: 21-28.
12. Lawton JS, Hsia PW, McClain LC et al. Myocardial oxygen consumption in the rabbit heart after ischemia: hyperpolarized arrest with pinacidil versus depolarized hyperkalemic arrest. Circulation 1997; 91: II-247-52.
13. Jayawant AM, Lawton JS, Hsia PW et al. Hyperpolarized cardioplegic arrest with nicorandil: advantages over other potassium channel openers. Circulation 1997; 96: II-240-46.
14. Obata T. Adenosine production and its role in protection against ischemic and reperfusion injury of the myocardium. Nippon Yakurigaka Zasshi 2002; 19: 273-79.
15. Lawton JS, Sepic JD, Allen CT, Hsia PW, Damiano RJ Jr. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann Thorac Surg 1996; 62: 31-38.
16. Steensrud T, Nordhaug D, Husnes KV et al. Replacing potassium with nicorandil in cold St. Thomas' Hospital cardioplegia improves preservation of energetics and function in pig hearts. Ann Thorac Surg 2004; 77: 1391-37.
17. Saeed M, Watzingor N, Krombach GA et al. Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model. Radiology 2002; 224: 830-37.
18. Maskal SL, Cohen NM, Hsia PW et al. Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim. J Thorac Cardiovasc Surg 1995; 110: 1083-95.
19. Mccully JD, Tsukube T, Atake K et al. Myocardial cytosolic calcium accumulation during ischemia-reperfusion: the effects of aging and cardioplegia. J Card Surg 1994; 9: 449-52.
20. Damiano RJ Jr, Cohen NM. Hyperpolarized arrest attenuates myocardial stunning following global surgical ischemia: an alternative to traditional hyperkalemic cardioplegia? J Card Surg 1998; 9: 517-25.
21. Cohen NM, Wise RM, Wechsler AS et al. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection? J Thorac Cardiovasc Surg 1999; 106: 317-28.